A.M. MUKHETDINOVA¹, S.A. LAPSHINA¹, Z.N. GABDULLINA², N.G. SHAMSUTDINOVA¹, E.V. SUKHORUKOVA², L.I. BADRUTDINOVA¹

¹Kazan State Medical University, Kazan

²Republic Clinical Hospital, Kazan

 Contact details:

Mukhetdinova A.M. — resident doctor of the Department of Hospital Therapy

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-996-693-19-10, e-mail: aigul.muhetdinova@yandex.ru

The article presents a clinical case of systemic scleroderma and polymyositis in a young female patient. Notable is a rather rapid development of symptoms beginning with Raynaud’s syndrome, scleroderma skin lesion, and visceral pathology against the background of immunologic activity. Along with this, there were signs of polymyositis: weakness of proximal muscle groups, high indices of muscle enzymes, and positive electromyographic data. After SARS-CoV-2 vaccination, the patient noted a worsening of her general condition, increased muscle weakness and the appearance of new symptoms such as dysphagia, dysphonia, enlarged cervical lymph nodes, shortness of breath, and cough. The examination revealed vocal fold paralysis, paresis of the right side of the larynx and soft palate, and pulmonary hypertension. The results of the examination of the muscular component implied a primary muscular lesion.

Key words: overlap syndrome, systemic sclerosis, polymyositis.

REFERENCES

1. Pepmueller P.H. Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology. Mo Med, 2016, vol. 113 (2).
2. Starovoytova M.N., Desinova O.V., Gusev N.G. et al. Cross forms of systemic scleroderma. Nauchno-prakticheskaya revmatologiya, 2007, vol. 45, no. 4, pp. 18–23 (in Russ.).
3. Klinicheskie rekomendatsii. Diagnostika i lechenie progressiruyushchego sistemnogo skleroza. Assotsiatsiya revmatologov Rossii [Clinical recommendations. Diagnosis and treatment of progressive systemic sclerosis. Association of Rheumatologists of Russia], 2016.
4. Assotsiatsiya revmatologov Rossii [Association of Rheumatologists of Russia], available at:http://rheumatolog.ru/patient/about_rz/zabolevaniya/polimiozit/index.php?sphrase_id=2281
5. Kreuter A., Burmann S.N., Burkert B. et al. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination. The Journal of the European Academy of Dermatology and Venereology, 2021, vol. 35 (11), pp. 733–735.
6. Nasonov E.L., Lila A.M., Mazurov V.I. et al. Coronavirus disease 2019 (COVID-19) and immunoinflammatory rheumatic diseases. Nauchno-prakticheskaya revmatologiya, 2021, vol. 59 (3), pp. 239–254 (in Russ.).